Cargando…
Macrophage Membrane-Camouflaged shRNA and Doxorubicin: A pH-Dependent Release System for Melanoma Chemo-Immunotherapy
Improving the efficacy of melanoma treatment remains an important global challenge. Here, we combined chemotherapy with protein tyrosine phosphatase nonreceptor type 2(Ptpn2) based immunotherapy in an effort to address this challenge. Short-hairpin RNA (shRNA) targeting Ptpn2 was coencapsulated with...
Autores principales: | Yang, Chengli, Ming, Yang, Zhou, Kai, Hao, Ying, Hu, Danrong, Chu, Bingyang, He, Xinlong, Yang, Yun, Qian, Zhiyong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AAAS
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8851070/ https://www.ncbi.nlm.nih.gov/pubmed/35233535 http://dx.doi.org/10.34133/2022/9768687 |
Ejemplares similares
-
Tumor-targeted/reduction-triggered composite multifunctional nanoparticles for breast cancer chemo-photothermal combinational therapy
por: Yang, Yun, et al.
Publicado: (2022) -
Construction of shRNA lentiviral vector
por: Song, Hong, et al.
Publicado: (2010) -
Oxygen-generating Hybrid Polymeric Nanoparticles with Encapsulated Doxorubicin and Chlorin e6 for Trimodal Imaging-Guided Combined Chemo-Photodynamic Therapy
por: Hu, DanRong, et al.
Publicado: (2018) -
Growth inhibition and chemo-radiosensitization of esophageal squamous cell carcinoma by survivin-shRNA lentivirus transfection
por: Zhou, Changlin, et al.
Publicado: (2018) -
Optimized PCR Conditions and Increased shRNA Fold Representation Improve Reproducibility of Pooled shRNA Screens
por: Strezoska, Žaklina, et al.
Publicado: (2012)